BDBM50275659 (S)-2-((R)-3-(hexyloxy)tetradecanamido)-3-((2R,3R,4R,5S,6R)-3-((R)-3-(hexyloxy)tetradecanamido)-4-((R)-3-(hexyloxy)tetradecanoyloxy)-6-(hydroxymethyl)-5-(phosphonooxy)tetrahydro-2H-pyran-2-yloxy)propanoic acid::CHEMBL501231

SMILES CCCCCCCCCCC[C@H](CC(=O)N[C@@H](CO[C@@H]1O[C@H](CO)[C@@H](OP(O)(O)=O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OCCCCCC)[C@H]1NC(=O)C[C@@H](CCCCCCCCCCC)OCCCCCC)C(O)=O)OCCCCCC

InChI Key InChIKey=SPDGRZAREUGVDZ-FYWAMUSJSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50275659   

TargetToll-like receptor 4(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50275659((S)-2-((R)-3-(hexyloxy)tetradecanamido)-3-((2R,3R,...)
Affinity DataIC50:  5.30nMAssay Description:Antagonist activity at TLR4 in human PBMC assessed as inhibition of LPS-stimulated TNFalpha production preincubated for 30 mins before LPS challenge ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed